On October 24, US banking regulators, the Office of the Comptroller of the Currency, Board of Governors of the Federal Reserve System, and Federal Deposit Insurance Corporation (the “agencies”), issued long-awaited guidance on how large financial institutions should manage financial risks associated with climate change.
On October 30, 2023, President Biden issued an expansive Executive Order (EO) on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI), aiming to establish standards for AI technology to address related potential benefits and risks.
On October 13, 2023, California Governor Gavin Newsom signed a first-of-its-kind bill related to an industry-wide minimum wage in California. SB 525 impacts the health care industry and sets a minimum wage schedule that employers in the health care industry must follow.
Costs to clean up environmentally impacted real estate have continued to increase. A variety of factors have caused this trend including: listing of new contaminants, enhanced focus on contamination pathways like vapor intrusion, and changed circumstance caused by infrastructure challenges from shifting weather patterns and greater population density all pose risks to parties fulfilling cleanup obligations.
In light of the banking failures of Silicon Valley Bank, Signature Bank and First Republic (as well as Credit Suisse), this summer, the Federal Reserve and the FDIC proposed guidance and rules for larger banks.
It’s back . . . like a bad penny or another season of “Bachelor in Paradise.” Last week, the National Labor Relations Board (NLRB or Board) announced the return of its new and expanded “BFI standard” for determining “joint employer” status.
Beginning on November 1, 2023, employees receiving paid benefits under the Massachusetts Paid Family and Medical Leave law (PFML) can supplement, or “top off,” the state paid benefit with other accrued paid time off such as vacation, personal, sick time, or a combined PTO (paid time off) benefit.
Here we are in fourth quarter of 2023 already! As companies start wrapping up 2023 and preparing and modeling for 2024, we thought it was a good time to highlight five regulatory developments, changes, or challenges on the horizon for pharmaceutical manufacturers operating in the US market:
Every year, thousands of applications are filed with the Federal Communications Commission (FCC) by defense contractors and equipment manufacturers seeking approval for experimental wireless operations in support of National Security objectives.
In the latest installment of WorldSmart, Hunter Carter is joined by Partner Malcolm McNeil and the CEO of FLOGEN Technologies, Dr. Florian Kongoli, to explore the intricate relationship between sustainability, technology, and the intersection of science, law, and medicine.
The US Department of Justice (DOJ) has issued its inaugural report highlighting recent activities related to the incorporation of environmental justice (EJ) principles into its enforcement efforts.
On October 25, 2023, the American Shrimp Processors Association (APSA) filed antidumping duty (AD) petitions on frozen warmwater shrimp from Ecuador and Indonesia, and countervailing duty (CVD) petitions on the same product from Ecuador, India, Indonesia, and Vietnam.
Renewable energy developers have one final opportunity to comment on changes to the rules that govern the procurement of renewable energy credits in Illinois.
The US Securities and Exchange Commission (SEC) Division of Examinations recently released its 2024 Examinations Priorities, a yearly report that provides insight into the Division’s areas of focus to improve compliance, prevent fraud, monitor risk, and inform policy.
On October 7, California Governor Gavin Newson signed into law AB-418, the California Food Safety Act, which completely bans, on safety grounds, the use in food of four additives that are considered safe by the US Food and Drug Administration (FDA). The ban becomes effective January 1, 2027.
The Federal Communications Commission (FCC) has launched a comprehensive inquiry designed to explore ways the Commission’s Mapping Broadband Health in America platform could be expanded and enhanced to help better leverage digital health tools to improve maternal care.
The US Supreme Court has announced it will evaluate whether “impact fees” associated with permits can violate the Fifth Amendment to the US Constitution.
As we highlighted in the Family Office Newsletter’s pages in June, the Corporate Transparency Act (CTA) is slated to go into effect on January 1, 2024.
James Kim has been invited back to present a webinar to members of the Canadian Transportation Equipment Association (CTEA) on October 25, 2023. The association roster currently tops 500 members representing key companies supplying the North American heavy and medium transportation sector.
As we discussed in our September 25 publishing, Everybody’s Got Something to Hide Except Me and My Monkey: IRS Issues Moratorium on Processing New Employee Retention Credit Claims, the IRS previously stated that it was finalizing details for a special withdrawal option for taxpayers.
On October 3, the US Food and Drug Administration (FDA) issued a proposed rule regarding the regulation of in vitro diagnostic products (IVDs).
Every year, thousands of applications are filed with the Federal Communications Commission (FCC) by defense contractors and equipment manufacturers seeking approval for experimental wireless operations in support of National Security objectives.